260 related articles for article (PubMed ID: 12115983)
1. Severe exacerbation of hepatitis C-associated vasculitic neuropathy following treatment with interferon alpha: a case report and literature review.
Boonyapisit K; Katirji B
Muscle Nerve; 2002 Jun; 25(6):909-13. PubMed ID: 12115983
[TBL] [Abstract][Full Text] [Related]
2. [Peripheral neuropathy during a second cycle of treatment with high doses of interferon-alpha in a patient with hepatitis C, and a review of the literature].
Téllez-Zenteno JF; Negrete-Pulido O; Nuñez M; Estañol-Vidal B; García-Ramos G
Rev Neurol; 2002 Oct 1-15; 35(7):644-6. PubMed ID: 12389150
[TBL] [Abstract][Full Text] [Related]
3. Exacerbation of peripheral neuropathy during alpha-interferon therapy in a patient with mixed cryoglobulinemia and hepatitis B virus infection.
La Civita L; Zignego AL; Lombardini F; Monti M; Longombardo G; Pasero G; Ferri C
J Rheumatol; 1996 Sep; 23(9):1641-3. PubMed ID: 8877939
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus acute quadriparetic vasculitic neuropathy responsive to cyclophosphamide.
Souayah N; Sander HW; Menkes DL; Khella SL
Neurol Neurophysiol Neurosci; 2006 Sep; ():5. PubMed ID: 17260082
[TBL] [Abstract][Full Text] [Related]
5. [Cryoglobulinemia and hepatitis c: worsening of peripheral neuropathy after interferon alpha treatment].
Lidove O; Cacoub P; Hausfater P; Wechsler B; Frances C; Leger JM; Piette JC
Gastroenterol Clin Biol; 1999 Mar; 23(3):403-6. PubMed ID: 10384347
[TBL] [Abstract][Full Text] [Related]
6. Is interferon-alpha therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study.
Bargiggia S; Thorburn D; Anderloni A; Ardizzone S; Giorgi A; Bianchi Porro G; Parente F
Aliment Pharmacol Ther; 2005 Aug; 22(3):209-15. PubMed ID: 16091058
[TBL] [Abstract][Full Text] [Related]
7. Fulminant central nervous system demyelination associated with interferon-alpha therapy and hepatitis C virus infection.
Höftberger R; Garzuly F; Dienes HP; Grubits J; Rohonyi B; Fischer G; Hanzely Z; Lassmann H; Budka H
Mult Scler; 2007 Nov; 13(9):1100-6. PubMed ID: 17967838
[TBL] [Abstract][Full Text] [Related]
8. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
[TBL] [Abstract][Full Text] [Related]
9. Vasculitic neuropathy--electrodiagnostic findings and association with malignancies.
Zivković SA; Ascherman D; Lacomis D
Acta Neurol Scand; 2007 Jun; 115(6):432-6. PubMed ID: 17511855
[TBL] [Abstract][Full Text] [Related]
10. Exacerbation of psoriasis due to interferon-alpha treatment of chronic active hepatitis.
Georgetson MJ; Yarze JC; Lalos AT; Webster GF; Martin P
Am J Gastroenterol; 1993 Oct; 88(10):1756-8. PubMed ID: 8213720
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune disease complicating antiviral therapy for hepatitis C virus infection.
Wilson LE; Widman D; Dikman SH; Gorevic PD
Semin Arthritis Rheum; 2002 Dec; 32(3):163-73. PubMed ID: 12528081
[TBL] [Abstract][Full Text] [Related]
12. Vasculitic neuropathy.
Sampaio L; Silva LG; Terroso G; Nadais G; Mariz E; Ventura F
Acta Reumatol Port; 2011; 36(2):102-9. PubMed ID: 21841729
[TBL] [Abstract][Full Text] [Related]
13. [Mononeuropathy multiplex in a patient receiving interferon alpha therapy for chronic hepatitis C].
Maeda M; Ohkoshi N; Hisahara S; Mizusawa H; Shoji S
Rinsho Shinkeigaku; 1995 Sep; 35(9):1048-50. PubMed ID: 8565346
[TBL] [Abstract][Full Text] [Related]
14. Axonal neuropathy in a patient receiving interferon-alpha therapy for chronic hepatitis C.
Tambini R; Quattrini A; Fracassetti O; Nemni R
J Rheumatol; 1997 Aug; 24(8):1656-7. PubMed ID: 9263170
[No Abstract] [Full Text] [Related]
15. Interferon-alpha associated arthritis.
Chung A; Older SA
J Rheumatol; 1997 Sep; 24(9):1844-5. PubMed ID: 9292816
[TBL] [Abstract][Full Text] [Related]
16. Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary.
Collins MP; Dyck PJ; Gronseth GS; Guillevin L; Hadden RD; Heuss D; Léger JM; Notermans NC; Pollard JD; Said G; Sobue G; Vrancken AF; Kissel JT;
J Peripher Nerv Syst; 2010 Sep; 15(3):176-84. PubMed ID: 21040139
[TBL] [Abstract][Full Text] [Related]
17. [Cryoglobulinemic peripheral neuropathy in hepatitis C virus infection: clinical and anatomical correlations of 22 cases].
Taieb G; Maisonobe T; Musset L; Cacoub P; Léger JM; Bouche P
Rev Neurol (Paris); 2010 May; 166(5):509-14. PubMed ID: 20338607
[TBL] [Abstract][Full Text] [Related]
18. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
[TBL] [Abstract][Full Text] [Related]
19. Vasculitic neuropathy.
Kissel JT; Mendell JR
Neurol Clin; 1992 Aug; 10(3):761-81. PubMed ID: 1323752
[TBL] [Abstract][Full Text] [Related]
20. [Hepatitis C-associated vasculitic mononeuritis multiplex].
Heckmann JG; Engelhardt A; Druschky A; Blum HE; Neundörfer B
Dtsch Med Wochenschr; 1997 Feb; 122(9):259-62. PubMed ID: 9102291
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
